Global Insomnia Market to Reach US$ 6.6 Billion by 2032, Propelled by Rising Stress, Anxiety, and Lifestyle Changes Among the Masses

April 24, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Insomnia Market Report by Therapy Type (Non-Pharmacological Therapy, Pharmacological Therapy), Drug Class (Antidepressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), and Region 2024-2032”, the global insomnia market size reached US$ 5.2 Billion in 2023. Insomnia is a sleep disorder that affects a person's ability to fall asleep, stay asleep, or a combination of both. The condition of insomnia can be caused by another medical condition, or it can represent a symptom of a different medical condition. Symptoms of insomnia include difficulty falling asleep, staying asleep, waking up too early, or feeling unrefreshed after sleeping, as well as fatigue, irritability, and difficulty concentrating. This can lead to a variety of health problems, including depression and impaired cognitive function. There can be acute insomnia or chronic insomnia, characterized by episodes lasting a few days or weeks and chronic insomnia lasting a month or more. The causes of insomnia can range from medical conditions to lifestyle factors to psychological factors. In addition to behavioral therapy, medication, and lifestyle changes, insomnia can be managed with various treatments. 


Global Insomnia Market Trends:

The global market is majorly driven by the growing prevalence of sleep disorders due to work-related stress, anxiety, and lifestyle changes among the masses. In line with this, a considerable rise in shift work and travel jet lag leading to the development of specific treatment options for these conditions is propelling the market growth. Moreover, the growing awareness regarding the negative impact of insomnia on productivity, health, and overall quality of life among the masses have augmented the demand for insomnia treatment options. In addition to this, continual technological advancements in treatment, such as wearable sleep trackers, online cognitive behavioral therapy, and other digital health solutions to facilitate easy access and sleep pattern monitoring, are leading to a higher uptake of insomnia diagnostics and therapeutics. The market is further driven by the easy availability of effective insomnia medications across online and offline organized pharmacy retail channels. Apart from this, the increasing geriatric population that is more susceptible to chronic insomnia and sleep disorders is creating a positive outlook for the market. Furthermore, the rising mental health awareness among the masses is resulting in a higher recognition of insomnia as a co-morbid condition, thereby fueling the market growth. Some of the other factors contributing to the market include the increasing hectic lifestyle of the masses, rising prevalence of numerous mental illnesses, growing medical expenditure, and extensive research and development (R&D) activities conducted by key players. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 6.6 Billion by 2032, exhibiting a CAGR of 2.69% during 2024-2032. 


Market Summary:

  • Based on the therapy type, the market has been segmented into non-pharmacological therapy (hypnotherapy, cognitive behavioral therapy, medical devices, and others) and pharmacological therapy (prescription sleep aids and over-the-counter sleep aids).
  • On the basis of the drug class, the market has been divided into antidepressants, melatonin antagonist, benzodiazepines, nonbenzodiazepines, orexin antagonist, and others.
  • Based on the distribution channels, the market has been categorized into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies.
  • On the geographical front, the market has been segregated into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Astellas Pharma Inc., Aurobindo Pharma Limited, Biocodex, Eisai Co. Ltd., Mallinckrodt Pharmaceuticals, Merck & Co. Inc., Neurim Pharmaceuticals Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.), Takeda Pharmaceutical Company Limited and Vanda Pharmaceuticals Inc.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Therapy Type, Drug Class, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Astellas Pharma Inc., Aurobindo Pharma Limited, Biocodex, Eisai Co. Ltd., Mallinckrodt Pharmaceuticals, Merck & Co. Inc., Neurim Pharmaceuticals Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.), Takeda Pharmaceutical Company Limited and Vanda Pharmaceuticals Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Insomnia Market to Reach US$ 6.6 Billion by 2032, Propelled by Rising Stress, Anxiety, and Lifestyle Changes Among the Masses
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More